103 related articles for article (PubMed ID: 7636250)
1. Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis.
Yelton DE; Rosok MJ; Cruz G; Cosand WL; Bajorath J; Hellström I; Hellström KE; Huse WD; Glaser SM
J Immunol; 1995 Aug; 155(4):1994-2004. PubMed ID: 7636250
[TBL] [Abstract][Full Text] [Related]
2. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
[TBL] [Abstract][Full Text] [Related]
3. Determination of the relative affinities of antibody fragments expressed in Escherichia coli by enzyme-linked immunosorbent assay.
Watkins JD; Beuerlein G; Pecht G; McFadden PR; Glaser SM; Huse WD
Anal Biochem; 1997 Nov; 253(1):37-45. PubMed ID: 9356139
[TBL] [Abstract][Full Text] [Related]
4. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
[TBL] [Abstract][Full Text] [Related]
5. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD
J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938
[TBL] [Abstract][Full Text] [Related]
6. Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumor antigens.
Ramsland PA; Farrugia W; Bradford TM; Mark Hogarth P; Scott AM
J Mol Biol; 2004 Jul; 340(4):809-18. PubMed ID: 15223322
[TBL] [Abstract][Full Text] [Related]
7. Antibody engineering by codon-based mutagenesis in a filamentous phage vector system.
Glaser SM; Yelton DE; Huse WD
J Immunol; 1992 Dec; 149(12):3903-13. PubMed ID: 1460281
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen.
Yan X; Evans SV; Kaminki MJ; Gillies SD; Reisfeld RA; Houghton AN; Chapman PB
J Immunol; 1996 Aug; 157(4):1582-8. PubMed ID: 8759742
[TBL] [Abstract][Full Text] [Related]
9. Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.
Juárez-González VR; Riaño-Umbarila L; Quintero-Hernández V; Olamendi-Portugal T; Ortiz-León M; Ortíz E; Possani LD; Becerril B
J Mol Biol; 2005 Mar; 346(5):1287-97. PubMed ID: 15713481
[TBL] [Abstract][Full Text] [Related]
10. Structure-function studies of anti-3-fucosyllactosamine (Le(x)) and galactosylgloboside antibodies.
Snyder JG; Dinh Q; Morrison SL; Padlan EA; Mitchell M; Yu-Lee LY; Marcus DM
J Immunol; 1994 Aug; 153(3):1161-70. PubMed ID: 7913110
[TBL] [Abstract][Full Text] [Related]
11. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection.
Schier R; Bye J; Apell G; McCall A; Adams GP; Malmqvist M; Weiner LM; Marks JD
J Mol Biol; 1996 Jan; 255(1):28-43. PubMed ID: 8568873
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of loss and change of specificity resulting from random mutagenesis of an antibody VH region.
Casson LP; Manser T
J Immunol; 1995 Dec; 155(12):5647-54. PubMed ID: 7499849
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-1 beta.
Jackson JR; Sathe G; Rosenberg M; Sweet R
J Immunol; 1995 Apr; 154(7):3310-9. PubMed ID: 7897213
[TBL] [Abstract][Full Text] [Related]
14. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
15. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
16. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of avidity and fine specificity of anti-levan antibodies.
Brorson K; Thompson C; Wei G; Krasnokutsky M; Stein KE
J Immunol; 1999 Dec; 163(12):6694-701. PubMed ID: 10586066
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
19. Affinity maturation of a V(H)H by mutational hotspot randomization.
Yau KY; Dubuc G; Li S; Hirama T; Mackenzie CR; Jermutus L; Hall JC; Tanha J
J Immunol Methods; 2005 Feb; 297(1-2):213-24. PubMed ID: 15777944
[TBL] [Abstract][Full Text] [Related]
20. In vitro affinity maturation of a specificity-determining region-grafted humanized anticarcinoma antibody: isolation and characterization of minimally immunogenic high-affinity variants.
De Pascalis R; Gonzales NR; Padlan EA; Schuck P; Batra SK; Schlom J; Kashmiri SV
Clin Cancer Res; 2003 Nov; 9(15):5521-31. PubMed ID: 14654532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]